On February 12, 2024, at 16:00 CET (15:00 GMT), EHDN will be hosting a virtual platform meeting to discuss the recently published data on the Generation-HD1 trial (read more). The conference will consist of a presentation by the sponsor, Roche, followed by a Q&A session and a discussion by a panel on open (and answered) questions and the way forward.

The meeting is aimed at professionals, but all are welcome.

— — — Please save the date in your diary — — — More details will follow shortly — — —